Skip to record
ExecutivesFrederick W. Driscoll

Executive record

Frederick W. Driscoll

Director at Cellectar Biosciences, Inc.

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:frederick-w-driscollVersion: public-0As of: 2026-10-04

Not yet claimed11 published Claims5 sources
  • Director

Leadership, in context.

Connect capital, control, accountability, and evidence.

Published Claims11Within this recordEvidence sources5Inspect provenance and dates

Explore the record

ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.

Key Claims

Biography

Director since February 2018, appointed Chair July 22, 2024. Extensive CFO and CEO experience in biopharmaceutical companies including Novavax, Flexion Therapeutics, and OXiGENE. Audit committee financial expert.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.